During the past decade, Neurologie Brno sro conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 2 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 2 clinical trials were completed. i.e. 66.7% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Neurologie Brno sro" are "Migraine" (3 trials) and "Migraine Headache" (1 trials). Many other conditions were trialed in "Neurologie Brno sro" in a lesser frequency.

Most popular intervention types in "Neurologie Brno sro" are "Drug" (4 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Erenumab" (1 trials), "Erenumab 140mg" (1 trials), "Erenumab 70 mg" (1 trials) and "Galcanezumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Neurologie Brno sro" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Neurologie Brno sro". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Neurologie Brno sro, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Neurologie Brno sro, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".